Company intelligence / Profile preview

Jolley Marketing

United States

Ownership: Private
Development stage: Other

Overview

The company, through its subsidiary Creative Medical Technologies, is developing a portfolio of cell therapies and biologics for several difficult-to-treat indications. Highlighted products include AlloStem (allogenic perinatal tissue-derived cell program, clinical), ImmCelz (personalized immune therapy platform, pre-clinical), and regenerative treatments for urology and orthopedics. Specific clinical results are not provided in the search results[3][4].

Therapeutic areas: EndocrinologyRheumatologyWomen's HealthMen's HealthOther
Modalities: Cell therapySmall moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on Jolley Marketing.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jolley Marketing.

Explore the full profile